Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years. [electronic resource]
Producer: 20210428Description: 105568 p. digitalISSN:- 1872-6968
- Adolescent
- Adult
- Age Factors
- Aged
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Bevacizumab -- therapeutic use
- Brain Neoplasms -- physiopathology
- Chemoradiotherapy
- Chemoradiotherapy, Adjuvant
- Chemotherapy, Adjuvant
- Cohort Studies
- Craniotomy
- DNA Methylation
- DNA Modification Methylases -- genetics
- DNA Repair Enzymes -- genetics
- Female
- Glioblastoma -- physiopathology
- Humans
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Lomustine -- therapeutic use
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- physiopathology
- Neurosurgical Procedures
- Promoter Regions, Genetic
- Proportional Hazards Models
- Prospective Studies
- Quality of Life
- Radiotherapy
- Radiotherapy, Adjuvant
- Reoperation
- Survival Rate
- Temozolomide -- therapeutic use
- Tumor Suppressor Proteins -- genetics
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.